Table 2

Univariate log-rank analyses for disease-specific, metastasis-free, and urinary bladder recurrence-free survival
Parameter No. of cases Disease-specific survival Metastasis-free survival UB Recurrence-free survival
No. of events pvalue No. of events pvalue No. of events pvalue
Gender Male 158 28 0.8286 32 0.7904 43 0.0369*
Female 182 33 38 36
Age (years) <65 138 26 0.9943 30 0.8470 34 0.5107
≥65 202 35 40 45
Tumor side Right 177 34 0.7366 38 0.3074 44 0.6047
Left 154 26 32 32
Bilateral 9 1 0 3
Tumor location Renal pelvis 141 24 0.0079* 31 0.0659 33 0.1723
Ureter 150 22 25 32
Renal pelvis and ureter 49 15 14 14
Multifocality Single 273 48 0.0026* 52 0.0127* 64 0.1861
Multifocal 62 18 18 15
Primary tumor (T) Ta ~ T1 181 11 <0.0001* 19 <0.0001* 43 0.2688
T2 ~ T4 159 50 51 36
Nodal metastasis Negative (N0) 312 42 <0.0001* 55 <0.0001* 73 0.1422
Positive (N1 ~ N2) 28 19 15 6
Histological grade Low grade 56 4 0.0215* 3 0.0027* 14 0.0056*
High grade 284 57 67 65
Pattern of invasion Non-invasive/nodular 200 19 <0.0001* 27 <0.0001* 50 0.5398
Trabecular 58 12 13 14
Infiltrative 82 30 30 15
Vascular invasion Absent 234 24 <0.0001* 26 <0.0001* 55 0.1770
Present 106 37 44 24
Perineurial invasion Absent 321 50 <0.0001* 61 <0.0001* 75 0.2169
Present 19 11 9 4
Mitotic rate (per 10 high power fields) <10 173 27 0.1607 30 0.0823 43 0.9031
≥10 167 34 40 36
Adjuvant chemotherapy Not performed 311 54 0.4084 61 0.2151 70 0.2740
Performed 29 7 9 9
HuR cytoplasmic expression Low 170 13 <0.0001* 19 <0.0001* 33 0.0370*
High 170 48 51 46
Cyclin A expression Low 170 19 0.0035* 22 0.0015* 36 0.3784
High 170 42 48 43

* Statistically significant.

Liang et al.

Liang et al. BMC Cancer 2012 12:611   doi:10.1186/1471-2407-12-611

Open Data